Fortrea Holdings shares rise 17.45% intraday after insider bought $407,150 worth of shares.

Fortrea Holdings Inc. rose 17.45% in intraday trading, with the company being mentioned in multiple news events. One of the key events was an insider buying shares worth $407,150, which is often seen as a bullish indicator. Additionally, Fortrea was highlighted for its expertise in ophthalmology studies and medical device trials, as it will be working with Ainnova Tech on a clinical trial for the early detection of diabetic retinopathy. This collaboration and the positive market sentiment towards AI in healthcare likely contributed to the stock's significant increase.